Before you sell to, join or invest in Gateway Biotechnology, Inc.
MentionFox check on Gateway Biotechnology, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/gateway-biotechnology-inc-form-d-25000001
Check Gateway Biotechnology, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Gateway Biotechnology, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Gateway Biotechnology, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-05.
Gateway Biotechnology, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 5, 2025. The filing reports $633K sold. Its industry group is Biotechnology. It names Jianxin Bao (Executive Officer), Richard Chole (Director), Philip Perez (Director) (SEC Form D, June 5, 2025).
Is this your company?
Sell to companies like Gateway Biotechnology, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Gateway Biotechnology, Inc.
Free to see. No signup.
More on the people and the money behind Gateway Biotechnology, Inc., from the filings we hold.
Biotechnology raises by companies based in North Carolina, filed within 90 days of this one, largest first.
Get an email when Gateway Biotechnology, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Gateway Biotechnology, Inc. raises, hires or launches. No email unless you switch it on.
Watch Gateway Biotechnology, Inc. →Get the full cited report on Gateway Biotechnology, Inc.
What the filing shows about Gateway Biotechnology, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Gateway Biotechnology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Gateway Biotechnology, Inc.'s address as 3805 Stoney Brook Drive, Durham, NC 27705.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Gateway Biotechnology, Inc. See pricing
Gateway Biotechnology, Inc. is a registered filer with the SEC (CIK 2071358) and has filed since 2025-06-05. 1 filing is on record, the latest on 2025-06-05.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Gateway Biotechnology, Inc.'s Form D of 2025-06-05 names Jianxin Bao, Richard Chole and Philip Perez as its officers, directors or promoters.
Its new offerings report $633K sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Gateway Biotechnology Inc. - Developing First-in-Class Drug Therapies for Hearing Disorders
The title and description the site itself served, answering 200, after redirecting from https://gtwbio.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Jianxin Bao is named as Executive Officer on the Form D that Gateway Biotechnology, Inc. filed with the SEC on 5 June 2025, one of 3 people that filing names.
Richard Chole is named as Director on the Form D that Gateway Biotechnology, Inc. filed with the SEC on 5 June 2025, one of 3 people that filing names.
Philip Perez is named as Director on the Form D that Gateway Biotechnology, Inc. filed with the SEC on 5 June 2025, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2025-06-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Gateway Biotechnology, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Gateway Biotechnology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Gateway Biotechnology, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Gateway Biotechnology, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Gateway Biotechnology, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-02 (gtwbio.com).
Each opens in a new tab, filled in for Gateway Biotechnology, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Raleigh-Durham
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/gateway-biotechnology-inc-form-d-25000001